Association of Thrombocytopenia, Revascularization, and In-Hospital Outcomes in Patients with Acute Myocardial Infarction.

[1]  R. Jackson,et al.  Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy , 2018, JAMA.

[2]  Deepak L. Bhatt,et al.  The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum , 2017, European heart journal.

[3]  R. Mehran,et al.  Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters , 2017, JAMA cardiology.

[4]  P. Rosseel,et al.  Does a Platelet Transfusion Independently Affect Bleeding and Adverse Outcomes in Cardiac Surgery? , 2017, Anesthesiology.

[5]  S. Bangalore,et al.  Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery , 2017, JAMA cardiology.

[6]  E. Oikonomou,et al.  The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis. , 2016, Thrombosis research.

[7]  G. Stone,et al.  Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention. , 2016, The Canadian journal of cardiology.

[8]  R. Goel,et al.  Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. , 2015, Blood.

[9]  H. White,et al.  Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome. , 2014, American heart journal.

[10]  G. Levine,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.

[11]  Laura Mauri,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.

[12]  J. Logie,et al.  Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom , 2011, Advances in therapy.

[13]  D. Kallmes,et al.  Patient Outcomes With Endovascular Embolectomy Therapy for Acute Ischemic Stroke: A Study of the National Inpatient Sample 2006 to 2008 , 2011, Stroke.

[14]  H. White,et al.  Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. , 2011, American heart journal.

[15]  W. Gibler,et al.  Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical Practice , 2009, Circulation.

[16]  J. Gore,et al.  Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). , 2009, The American journal of cardiology.

[17]  J. Ivanov,et al.  Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention. , 2008, American heart journal.

[18]  J. Gore,et al.  Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? , 2007, Circulation.

[19]  J. Ware,et al.  Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. , 2007, JAMA.

[20]  S. Yusuf,et al.  Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes , 2006, Circulation.

[21]  R. Califf,et al.  Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. , 2005, The American journal of cardiology.

[22]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[23]  N. Weissman,et al.  Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. , 2003, The American journal of cardiology.

[24]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[25]  R. Califf,et al.  Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. , 1999, Circulation.

[26]  福井良治,et al.  当院におけるPCI(Percutaneous Coronary Intervention)の治療成績 , 2003 .

[27]  Anne Elixhauser,et al.  The healthcare cost and utilization project: an overview. , 2002, Effective clinical practice : ECP.